Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet? Emily BrooksSusan E. TettChristine E. Staatz Review Article 02 May 2016 Pages: 1295 - 1335
Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C Polina GermanAnita MathiasBrian P. Kearney Review Article 18 May 2016 Pages: 1337 - 1351
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products Gail D. AndersonLingtak-Neander Chan Review Article 22 April 2016 Pages: 1353 - 1368
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide Guillemette E. BenoistRianne J. HendriksNielka P. van Erp Review Article Open access 22 April 2016 Pages: 1369 - 1380
Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients Morgane CauletThierry LecomteDavid Ternant Original Research Article 16 June 2016 Pages: 1381 - 1394
Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent–Metabolite Population Pharmacokinetic Model Sarah F. CookChris StockmannJohn N. van den Anker Original Research Article 21 May 2016 Pages: 1395 - 1411
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis Rune V. OvergaardKristin C. PetriChristine B. Jensen Original Research Article Open access 19 May 2016 Pages: 1413 - 1422
Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects Takayuki KatsubeToru IshibashiToshihiro Wajima Original Research Article 21 May 2016 Pages: 1423 - 1433
Evaluation of Cytochrome P450 3A4-Mediated Drug–Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation Nageshwar R. BudhaTao JiJin Y. Jin Original Research Article 25 May 2016 Pages: 1435 - 1445
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients Nielka P. van ErpCarla M. van HerpenRob ter Heine Original Research Article Open access 14 June 2016 Pages: 1447 - 1456
Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus Julia K. MaderLene JensenThomas R. Pieber Short Communication Open access 09 June 2016 Pages: 1457 - 1463